Corbus Pharmaceuticals Holdings (CRBP) Total Debt Growth (1y) (2021 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) Total Debt Growth (1y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn | - |
| 10 | Corbus Pharmaceuticals Holdings | 113.66 Mn | 85.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -41.40% |
| Mar 31, 2024 | -32.75% |
| Dec 31, 2023 | 69.41% |
| Sep 30, 2023 | -7.37% |
| Jun 30, 2023 | -3.94% |
| Mar 31, 2023 | 0.40% |
| Dec 31, 2022 | 0.27% |
| Sep 30, 2022 | 3.88% |
| Jun 30, 2022 | 3.89% |
| Mar 31, 2022 | 3.89% |
| Dec 31, 2021 | 3.89% |
| Sep 30, 2021 | 3.89% |